関節内補充療法のグローバル市場2023-2030:1回注射、3回注射、5回注射

◆英語タイトル:Viscosupplementation Market Size, Share & Trends Analysis Report By Product (Single Injection, Three Injection, Five Injection), By End-use (Hospitals, Orthopedic Clinics/ASCs), By Region (Asia Pacific, Europe), And Segment Forecasts, 2023 - 2030

Grand View Researchが発行した調査報告書(GRV23OCT072)◆商品コード:GRV23OCT072
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2023年8月
◆ページ数:120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,360,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

関節内補充療法市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の関節内補充療法市場規模は2030年までに91億4000万米ドルに達し、2023年から2030年までの年平均成長率は9.58%で推移すると予測されています。市場成長の背景には、高齢者人口の増加、高齢者の変形性関節症患者の増加、研究開発への多額の投資など、いくつかの重要な要因があります。CDCによると、現在米国では成人の約25%が何らかの関節炎を経験しており、この数は2040年までに7,800万人に達すると予想されています。その結果、関節内補充療法の需要は今後数年で急増すると予測されています。

さらに、企業による買収、契約、提携、パートナーシップなどの主要戦略の採用が増加していることも、市場の成長を後押ししています。例えば、2021年12月、医療技術企業であるAvanos Medical社は、変形性膝関節症治療のための関節内補充療法療法の先駆者であるOrthogenRx社を買収しました。買収額は約1,600億米ドルでした。アバノスは、TriViscやGenVisc850などのFDA承認製品を活用し、この分野で効果的なソリューションを提供しています。さらに、高齢者人口に関する有利な償還政策が市場成長の好機となる見込みです。

ここ数年、韓国、ロシア、中国などの発展途上国では整形外科医の数が著しく増加しています。この傾向は、米国と比較して患者数が多く、未開拓の機会を誇るアジア太平洋地域における大きな成長の可能性を示しています。その結果、アジア諸国の市場参入企業による新製品の投入が、市場のさらなる成長を促進すると予想されます。

関節内補充療法市場レポートハイライト

- 2022年には3回注射製品が43.1%以上のシェアを占め市場を席巻、予測期間中もその優位性は続く見込みです。

- 単回注射製品は比較的新しい市場であり、多くの医療技術企業が単回および3回注射サービスの承認に向けて臨床試験を実施中です。

- 整形外科クリニック/ASCのエンドユースセグメントが2022年に最大のシェアを占めたのは、施設や管理の容易さ、技術のアップグレードが理由。外来患者サービスを提供する施設は、高齢者人口にとってより実行しやすいです。同分野は予測期間を通じて優位性を維持する見込みです。

- 老年人口が多いアジア太平洋地域が市場を支配し、2022年には45.57%の最大収益シェアを占めました。

- 欧州は、医療の進歩や未開拓のビジネスチャンスの存在により、予測期間中のCAGRが約10.7%と最速になると予測されます。また、同地域では老年人口が増加し、変形性関節症の症例が増えると予測されています。

第1章. 方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 関節内補充療法市場:製品別予測・動向分析
第5章. 関節内補充療法市場:最終用途別予測・動向分析
第6章. 関節内補充療法市場:地域別予測・動向分析
第7章. 競争状況

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Methodology and Scope
1.1. Research Process
1.2. Information Procurement
1.2.1. Purchased database:
1.2.1.1. GVR’s internal database
1.2.2. Market Formulation & Validation
1.3. Research Methodology
1.4. Research Scope and Assumptions
1.5. Research Methodology
1.5.1. Region Market: CAGR Calculation
1.5.2. Region-Based Segment Share Calculation
1.6. List of Data Sources
Chapter 2 Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.4. Viscosupplementation Market Snapshot
Chapter 3 Viscosupplementation Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Industry Challenge
3.3. Viscosupplementation Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of Substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
3.4. Impact of COVID-19 on the Viscosupplementation Market
Chapter 4 Viscosupplementation Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Viscosupplementation Market: Product Movement Analysis, USD Million, 2022 & 2030
4.2.1. Single Injection
4.2.1.1. Single Injection Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.2.2. Three Injection
4.2.2.1. Three Injection Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.2.3. Five Injection
4.2.3.1. Five Injection Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 5 Viscosupplementation Market: End-use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Viscosupplementation Market: End-use Movement Analysis, USD Million, 2022 & 2030
5.2.1. Hospitals
5.2.1.1. Hospitals Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
5.2.2.1. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 6 Viscosupplementation Market: Regional Estimates & Trend Analysis
6.1. Definition & Scope
6.2. Regional Market Share Analysis, 2022 & 2030
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot
6.5. Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
6.5.1. North America
6.5.1.1. North America Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.1.2. U.S.
6.5.1.2.1. Key Country Dynamics
6.5.1.2.2. Competitive Scenario
6.5.1.2.3. Regulatory Framework
6.5.1.2.4. Reimbursement Scenario
6.5.1.2.5. U.S. Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.1.3. Canada
6.5.1.3.1. Key Country Dynamics
6.5.1.3.2. Competitive Scenario
6.5.1.3.3. Regulatory Framework
6.5.1.3.4. Reimbursement Scenario
6.5.1.3.5. Canada Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.2. Europe
6.5.2.1. Europe Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.2.2. UK
6.5.2.2.1. Key Country Dynamics
6.5.2.2.2. Competitive Scenario
6.5.2.2.3. Regulatory Framework
6.5.2.2.4. Reimbursement Scenario
6.5.2.2.5. UK Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.2.3. Germany
6.5.2.3.1. Key Country Dynamics
6.5.2.3.2. Competitive Scenario
6.5.2.3.3. Regulatory Framework
6.5.2.3.4. Reimbursement Scenario
6.5.2.3.5. Germany Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.2.4. France
6.5.2.4.1. Key Country Dynamics
6.5.2.4.2. Competitive Scenario
6.5.2.4.3. Regulatory Framework
6.5.2.4.4. Reimbursement Scenario
6.5.2.4.5. France Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.2.5. Italy
6.5.2.5.1. Key Country Dynamics
6.5.2.5.2. Competitive Scenario
6.5.2.5.3. Regulatory Framework
6.5.2.5.4. Reimbursement Scenario
6.5.2.5.5. Italy Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.2.6. Spain
6.5.2.6.1. Key Country Dynamics
6.5.2.6.2. Competitive Scenario
6.5.2.6.3. Regulatory Framework
6.5.2.6.4. Reimbursement Scenario
6.5.2.6.5. Spain Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.2.7. Denmark
6.5.2.7.1. Key Country Dynamics
6.5.2.7.2. Competitive Scenario
6.5.2.7.3. Regulatory Framework
6.5.2.7.4. Reimbursement Scenario
6.5.2.7.5. Denmark Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.2.8. Sweden
6.5.2.8.1. Key Country Dynamics
6.5.2.8.2. Competitive Scenario
6.5.2.8.3. Regulatory Framework
6.5.2.8.4. Reimbursement Scenario
6.5.2.8.5. Sweden Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.2.9. Norway
6.5.2.9.1. Key Country Dynamics
6.5.2.9.2. Competitive Scenario
6.5.2.9.3. Regulatory Framework
6.5.2.9.4. Reimbursement Scenario
6.5.2.9.5. Norway Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.3. Asia Pacific
6.5.3.1. Asia Pacific Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.3.2. Japan
6.5.3.2.1. Key Country Dynamics
6.5.3.2.2. Competitive Scenario
6.5.3.2.3. Regulatory Framework
6.5.3.2.4. Reimbursement Scenario
6.5.3.2.5. Japan Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.3.3. India
6.5.3.3.1. Key Country Dynamics
6.5.3.3.2. Competitive Scenario
6.5.3.3.3. Regulatory Framework
6.5.3.3.4. Reimbursement Scenario
6.5.3.3.5. India Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.3.4. China
6.5.3.4.1. Key Country Dynamics
6.5.3.4.2. Competitive Scenario
6.5.3.4.3. Regulatory Framework
6.5.3.4.4. Reimbursement Scenario
6.5.3.4.5. China Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.3.5. Australia
6.5.3.5.1. Key Country Dynamics
6.5.3.5.2. Competitive Scenario
6.5.3.5.3. Regulatory Framework
6.5.3.5.4. Reimbursement Scenario
6.5.3.5.5. Australia Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.3.6. Thailand
6.5.3.6.1. Key Country Dynamics
6.5.3.6.2. Competitive Scenario
6.5.3.6.3. Regulatory Framework
6.5.3.6.4. Reimbursement Scenario
6.5.3.6.5. Thailand Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.3.7. South Korea
6.5.3.7.1. Key Country Dynamics
6.5.3.7.2. Competitive Scenario
6.5.3.7.3. Regulatory Framework
6.5.3.7.4. Reimbursement Scenario
6.5.3.7.5. South Korea Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.4. Latin America
6.5.4.1. Latin America Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.4.2. Brazil
6.5.4.2.1. Key Country Dynamics
6.5.4.2.2. Competitive Scenario
6.5.4.2.3. Regulatory Framework
6.5.4.2.4. Reimbursement Scenario
6.5.4.2.5. Brazil Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.4.3. Mexico
6.5.4.3.1. Key Country Dynamics
6.5.4.3.2. Competitive Scenario
6.5.4.3.3. Regulatory Framework
6.5.4.3.4. Reimbursement Scenario
6.5.4.3.5. Mexico Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.4.4. Argentina
6.5.4.4.1. Key Country Dynamics
6.5.4.4.2. Competitive Scenario
6.5.4.4.3. Regulatory Framework
6.5.4.4.4. Reimbursement Scenario
6.5.4.4.5. Argentina Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.5. MEA
6.5.5.1. MEA Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.5.2. South Africa
6.5.5.2.1. Key Country Dynamics
6.5.5.2.2. Competitive Scenario
6.5.5.2.3. Regulatory Framework
6.5.5.2.4. Reimbursement Scenario
6.5.5.2.5. South Africa Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.5.3. Saudi Arabia
6.5.5.3.1. Key Country Dynamics
6.5.5.3.2. Competitive Scenario
6.5.5.3.3. Regulatory Framework
6.5.5.3.4. Reimbursement Scenario
6.5.5.3.5. Saudi Arabia Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.5.4. UAE
6.5.5.4.1. Key Country Dynamics
6.5.5.4.2. Competitive Scenario
6.5.5.4.3. Regulatory Framework
6.5.5.4.4. Reimbursement Scenario
6.5.5.4.5. UAE Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.5.5. Kuwait
6.5.5.5.1. Key Country Dynamics
6.5.5.5.2. Competitive Scenario
6.5.5.5.3. Regulatory Framework
6.5.5.5.4. Reimbursement Scenario
6.5.5.5.5. Kuwait Viscosupplementation Market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 7 Competitive Landscape
7.1. Company Categorization
7.2. Key Company Market Position Analysis
7.3. Key Company Market Share Analysis
7.4. Recent Development and Impact Analysis, by Key Market Participants
7.5. Company Profiles
7.5.1. Sanofi
7.5.1.1. Company Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Anika Therapeutics, Inc.
7.5.2.1. Company Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Seikagaku Corporation
7.5.3.1. Company Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Zimmer Biomet
7.5.4.1. Company Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic initiatives
7.5.5. Smith & Nephew PLC
7.5.5.1. Company Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic initiatives
7.5.6. Ferring Pharmaceutical B.V.
7.5.6.1. Company Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic initiatives
7.5.7. Lifecore Biomedical, LLC (Landec)
7.5.7.1. Company Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic initiatives
7.5.8. LG Life Sciences Ltd.
7.5.8.1. Company Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic initiatives
7.5.9. Fidia Farmaceutici S.p.A
7.5.9.1. Company Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic initiatives
7.5.10. F.Hoffmann-La Roche Ltd.
7.5.10.1. Company Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 4 North America Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 5 U.S. Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 6 U.S. Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 7 Canada Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 8 Canada Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 9 Europe Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 10 Europe Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 11 U.K. Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 12 U.K. Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 13 Germany Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 14 Germany Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 15 France Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 16 France Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 17 Italy Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 18 Italy Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 19 Spain Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 20 Spain Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 21 Sweden Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 22 Sweden Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 23 Denmark Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 24 Denmark Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 25 Norway Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 26 Norway Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 27 Asia Pacific Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 29 Japan Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 30 Japan Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 31 China Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 32 China Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 33 India Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 34 India Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 35 Australia Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 36 Australia Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 37 South Korea Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 38 South Korea Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 39 Thailand Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 40 Thailand Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 41 Latin America Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 42 Latin America Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 43 Brazil Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 44 Brazil Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 45 Mexico Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 46 Mexico Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 47 Argentina Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 48 Argentina Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 49 MEA Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 50 MEA Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 51 South Africa Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 52 South Africa Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 53 Saudi Arabia Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 54 Saudi Arabia Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 55 UAE Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 56 UAE Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 57 Kuwait Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 58 Kuwait Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 関節内補充療法のグローバル市場2023-2030:1回注射、3回注射、5回注射(Viscosupplementation Market Size, Share & Trends Analysis Report By Product (Single Injection, Three Injection, Five Injection), By End-use (Hospitals, Orthopedic Clinics/ASCs), By Region (Asia Pacific, Europe), And Segment Forecasts, 2023 - 2030)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆